Ingenuity
发表于 2025-3-23 11:39:17
http://reply.papertrans.cn/16/1587/158692/158692_11.png
领导权
发表于 2025-3-23 17:09:01
Ukraines no specific treatment of pharmaceutical products under the Ukrainian competition law. The law “On Protection of Economic Competition” (hereafter “Competition Law”) contains the main provisions regarding the protection of competition. In particular, the key provisions of Competition Law dealing wit
fetter
发表于 2025-3-23 19:50:36
http://reply.papertrans.cn/16/1587/158692/158692_13.png
珍奇
发表于 2025-3-24 00:17:38
http://reply.papertrans.cn/16/1587/158692/158692_14.png
Myelin
发表于 2025-3-24 05:21:24
Wolfgang Kersten,Kirsten A. Schröderral rules. New amendments of both Acts are currently in the pipeline, following European Directive 2014/104 on antitrust damages actions, which has to be implemented in the legal systems of all EU Member States by December 27, 2016.
languid
发表于 2025-3-24 08:03:21
E-Business in Produktionsnetzwerkention law and (iv) whether there is shared practice on budgetary and other public interest considerations. Particular attention is paid to market definition in de pharmaceutical sector, parallel trade and generic entry.
interpose
发表于 2025-3-24 11:36:42
Wissensmanagement im E-Commercevant competition law regulations, are directly applicable in the Czech Republic and therefore play a key role as regards the protection of competition in the Czech Republic. Nevertheless, this report focuses on national competition law.
Scintillations
发表于 2025-3-24 15:53:08
https://doi.org/10.1007/978-3-642-56831-2h infringements in the pharmaceutical sector relate to anticompetitive concerted actions (Article 6 of Competition Law), concerted actions on supply and use of goods (Article 8 of Competition Law), and abuse of dominance (Article 13 of Competition Law).
WITH
发表于 2025-3-24 22:11:57
Electronic Business und Multimediaf enforcement activity in this sector in the United States or, more recently, in the European Union. The Competition Commission has notably not had to struggle with reverse payment settlements and other issues at the crossroad of intellectual property and competition law.
Duodenitis
发表于 2025-3-25 00:40:11
http://reply.papertrans.cn/16/1587/158692/158692_20.png